{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:37:11Z","timestamp":1786361831388,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.diagmicrobio.2025.116888","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T11:13:08Z","timestamp":1746875588000},"page":"116888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["In vitro activity of amikacin combined with meropenem, colistin and ceftazidime\/avibactam against genetically distinct multidrug-resistant K. pneumoniae, A. baumannii and S. marcescens isolates using three methods"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9861-4796","authenticated-orcid":false,"given":"Saidy V\u00e1sconez","family":"Noguera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Farrel","family":"C\u00f4rtes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce Vanessa","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia Maria Dantas de Maio","family":"Carrilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sara","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Figueiredo","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauro Vieira Perdig\u00e3o","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00779-19","article-title":"Evaluation of the synergy of ceftazidime-avibactam in klebsiella pneumoniae and pseudomonas aeruginosa","volume":"63","author":"Mikhail","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics9110777","article-title":"Combination therapy with aminoglycoside in bacteremiasdue to esbl-producing enterobacteriaceae in icu","volume":"9","author":"Benetazzo","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0041-1742095","article-title":"Antibiotic combination therapy: A strategy to overcome bacterial resistance to aminoglycoside antibiotics","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11121420","article-title":"Drug repurposing approaches towards defeating multidrug-resistant gram-negative pathogens: novel polymyxin\/non-antibiotic combinations","volume":"11","author":"Koh Jing Jie","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1013939","article-title":"Effects of amikacin, polymyxin-B, and sulbactam combination on the pharmacodynamic indices of mutant selection against multi-drug resistant Acinetobacter baumannii","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0006","unstructured":"Ontong JC, Ozioma NF, Voravuthikunchai SP, et al. Synergistic antibacterial effects of colistin in combination with aminoglycoside, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates. 2021;1\u201318."},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0007","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2147\/IDR.S292431","article-title":"In vitro and in vivo effect of antimicrobial agent combinations against carbapenem-resistant klebsiella pneumoniae with different resistance mechanisms in China","volume":"14","author":"Liu","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0008","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jgar.2020.07.025","article-title":"Alternative drugs against multiresistant gram-negative bacteria","volume":"23","author":"Perdig\u00e3o Neto","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0009","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1128\/AAC.00873-15","article-title":"Can plazomicin alone or in combination be a therapeutic option against carbapenem-resistant Acinetobacter baumannii?","volume":"59","author":"Garc\u00eda-Salguero","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.116888_bib0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4103\/ijmm.IJMM_17_189","article-title":"An update on technical, interpretative and clinical relevance of antimicrobial synergy testing methodologies","volume":"35","author":"Laishram","year":"2017","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0011","first-page":"1914","article-title":"Comparison of three different In vitro methods of detecting synergy : time-kill","volume":"40","author":"White","year":"1996","journal-title":"Checkerboard E Test"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0012","doi-asserted-by":"crossref","unstructured":"Olajuyigbe OO, Afolayan AJ. In vitro synergy and time-kill assessment of interaction between Kanamycin and metronidazole against resistant bacteria. 2015;14:837\u2013843.","DOI":"10.4314\/tjpr.v14i5.14"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0013","unstructured":"Services H. Guidance for industry and FDA class II Special Controls Guidance document : antimicrobial susceptibility test (AST) systems preface public comment : additional copies : 2009;1\u201342."},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0014","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jgar.2019.08.026","article-title":"Association of blaNDM-1 with blaKPC-2 and aminoglycoside-modifying enzyme genes among Klebsiella pneumoniae, Proteus mirabilis and Serratia marcescens clinical isolates in Brazil","volume":"21","author":"Firmo","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0015","first-page":"1","article-title":"Synergistic activities of colistin combined with other antimicrobial agents against colistin-resistant Acinetobacter baumannii clinical isolates","volume":"17","author":"Almutairi","year":"2022","journal-title":"PLoS One [Internet]"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0016","first-page":"1","article-title":"Emergence of extensively drug-resistant and pandrug-resistant gram-negative bacilli in Europe","volume":"13","author":"Souli","year":"2008","journal-title":"Euro Surveill [Internet]"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0017","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1128\/AAC.01230-13","article-title":"Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems","volume":"57","author":"Zusman","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0018","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10096-005-0076-9","article-title":"Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"25","author":"Balke","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-020-01756-0","article-title":"Comparison of methods for the detection of in vitro synergy in multidrug-resistant gram-negative bacteria","volume":"20","author":"Gaudereto","year":"2020","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics12010093","article-title":"In vitro synergistic activity of antimicrobial combinations against carbapenem- and colistin-resistant Acinetobacter baumannii and Klebsiella pneumoniae","volume":"12","author":"Mantzana","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2022.1068840","article-title":"Susceptibility profile of bla OXA-23 and metallo-\u03b2-lactamases co-harbouring isolates of carbapenem resistant Acinetobacter baumannii (CRAB) against standard drugs and combinations","volume":"12","author":"Sharma","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph14060533","article-title":"The beta-lactam resistome expressed by aerobic and anaerobic bacteria isolated from human feces of healthy donors","volume":"14","author":"V\u00e1zquez-L\u00f3pez","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0023","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1093\/jac\/dkz389","article-title":"In vitro synergy of \u03b2-lactam combinations against KPC-producing Klebsiella pneumoniae strains","volume":"74","author":"Lawandi","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0024","doi-asserted-by":"crossref","unstructured":"Huang Y, Rana AP, Wenzler E, et al. Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae. 2021;1\u20138.","DOI":"10.1093\/jac\/dkab381"},{"key":"10.1016\/j.diagmicrobio.2025.116888_bib0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jgar.2019.12.009","article-title":"Resistance to ceftazidime\u2013avibactam and underlying mechanisms","volume":"22","author":"Wang","year":"2020","journal-title":"J Glob Antimicrob Resist"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325002111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325002111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:22:42Z","timestamp":1786360962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889325002111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0732889325002111"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116888","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of amikacin combined with meropenem, colistin and ceftazidime\/avibactam against genetically distinct multidrug-resistant K. pneumoniae, A. baumannii and S. marcescens isolates using three methods","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116888"}}